IFPA is proud to partner with PsoProtect and PsoProtectMe.
PsoProtect is an international registry for healthcare providers to report outcomes of COVID-19 in individuals with psoriasis. The registry's sister survey, PsoProtectMe, is collecting self-reported data from people living with psoriatic disease through the COVID-19 pandemic.
The results of these projects have increased our understanding of how the COVID-19 pandemic is affecting people with psoriatic disease. New insights will continue to inform clinical recommendations and better response to future emergencies.